Sign in

CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company

Aldeyra Therapeutics, Inc.

Sign in to watch
Ticker
ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
781-761-4904
Business address
23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
Former names
Aldexa Therapeutics, Inc., Neuron Systems Inc
  1. 4 Open-market buy Director bought 40,000 shares at $4.50 ($180,000)
  2. 4 Open-market buy President and CEO bought 22,223 shares at $4.50 ($100,004)
  3. 4 Open-market buy Director bought 4,444 shares at $4.50 ($19,998)
  4. 4 Open-market buy Director bought 4,444 shares at $4.50 ($19,998)
  5. 4 Open-market buy Chief Financial Officer bought 3,333 shares at $4.50 ($14,999)
  6. 4 Open-market buy 10% owner bought 893,025 shares at $4.50 ($4,018,613)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy 10% owner bought 700,000 shares at $5.00 ($3,500,000)
  16. 4 Grant or award President and CEO acquired 27,096 shares (grant or award)
  17. 4/A Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 12 · 223 filings